title: Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
abstract: Peptide presentation by MHC class II is of critical importance to the function of CD4+ T cells. HLA-DM resides in the endosomal pathway and edits the peptide repertoire of newly synthesized MHC class II molecules before they are exported to the cell surface. HLA-DM ensures MHC class II molecules bind high affinity peptides by targeting unstable MHC class II:peptide complexes for peptide exchange. Research over the past decade has implicated the peptide N-terminus in modulating the ability of HLA-DM to target a given MHC class II:peptide combination. In particular, attention has been focused on both the hydrogen bonds between MHC class II and peptide, and the occupancy of the P1 anchor pocket. We sought to solve the crystal structure of a HLA-DR1 molecule containing a truncated hemagglutinin peptide missing three N-terminal residues compared to the full-length sequence (residues 306-318) to determine the nature of the MHC class II:peptide species that binds HLA-DM. Here we present structural evidence that HLA-DR1 that is loaded with a peptide truncated to the P1 anchor residue such that it cannot make select hydrogen bonds with the peptide N-terminus, adopts the same conformation as molecules loaded with full-length peptide. HLA-DR1:peptide combinations that were unable to engage up to four key hydrogen bonds were also unable to bind HLA-DM, while those truncated to the P2 residue bound well. These results indicate that the conformational changes in MHC class II molecules that are recognized by HLA-DM occur after disengagement of the P1 anchor residue.
authors: Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
authors: Monika-Sarah E D
authors: MS
authors: Schulze
authors: Anne-Kathrin
authors: AK
authors: Anders
authors: Dhruv K
authors: DK
authors: Sethi
authors: Melissa J
authors: MJ
authors: Call
mesh_terms: D000595:Amino Acid Sequence; D001665:Binding Sites; D018360:Crystallography, X-Ray; D006681:HLA-D Antigens / Q000378:metabolism*; D015798:HLA-DR1 Antigen / Q000737:chemistry* / Q000378:metabolism*; D006388:Hemagglutinins / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D006860:Hydrogen Bonding; D008958:Models, Molecular; D008969:Molecular Sequence Data; D011487:Protein Conformation; D020349:Surface Plasmon Resonance
chemical_list: D006681:HLA-D Antigens; C084245:HLA-DM antigens; D015798:HLA-DR1 Antigen; D006388:Hemagglutinins
references: J Immunol. 2002 Nov 1;169(9):5109-17
references: 12391227
references: Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):734-8
references: 8570625
references: Immunity. 1995 Aug;3(2):197-205
references: 7648393
references: Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
references: 20057044
references: Methods Enzymol. 1997;276:307-26
references: 27754618
references: J Exp Med. 2002 Jul 15;196(2):173-83
references: 12119342
references: Cell. 1995 Jul 14;82(1):155-65
references: 7606781
references: Nature. 1990 Jun 14;345(6276):615-8
references: 2190094
references: Nature. 1994 Apr 7;368(6471):551-4
references: 8139689
references: Nature. 1992 Jan 30;355(6359):472-5
references: 18481394
references: Immunity. 2003 Aug;19(2):183-92
references: 12932352
references: Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
references: 20124702
references: Proc Natl Acad Sci U S A. 1994 May 10;91(10):4456-60
references: 8183931
references: Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12450-5
references: 11606721
references: Nat Immunol. 2011 Jan;12(1):54-61
references: 21131964
references: J Exp Med. 2000 Dec 18;192(12):1697-706
references: 11120767
references: Nature. 1991 Sep 12;353(6340):167-70
references: 1653903
references: Immunity. 1998 Nov;9(5):699-709
references: 9846491
references: J Biol Chem. 2000 Jan 21;275(3):2165-73
references: 10636922
references: J Exp Med. 1996 Nov 1;184(5):2019-24
references: 8920889
references: Nat Immunol. 2007 Jan;8(1):92-100
references: 17143275
references: Immunity. 2000 Oct;13(4):517-27
references: 11070170
references: Nature. 2004 Jan 8;427(6970):154-9
references: 14712275
references: Nature. 1993 Jul 1;364(6432):33-9
references: 8316295
references: Nature. 1994 Mar 17;368(6468):215-21
references: 8145819
references: J Immunol. 2010 Feb 1;184(3):1153-8
references: 20038641
references: Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9724-9
references: 8790398
references: Immunity. 1994 Dec;1(9):763-74
references: 7895165
references: Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19329-34
references: 22084083
references: J Exp Med. 1996 Dec 1;184(6):2153-65
references: 8976171
references: J Immunol. 2004 Jan 15;172(2):1109-17
references: 14707085
references: Nature. 1995 Jun 29;375(6534):802-6
references: 7596415
references: J Immunol. 2006 Apr 1;176(7):4208-20
references: 16547258
references: Cell. 2012 Dec 21;151(7):1557-68
references: 23260142
references: J Immunol. 1990 Mar 1;144(5):1849-56
references: 2307844
references: EMBO J. 1996 Nov 15;15(22):6144-54
references: 8947036
references: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
references: 15572765
references: J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
references: 19461840
references: Nature. 1993 Jun 24;363(6431):725-8
references: 8515815
references: J Immunol. 2009 Oct 1;183(7):4187-91
references: 19767569
references: Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13163-8
references: 9371817
references: J Immunol. 1999 Mar 15;162(6):3463-70
references: 10092802
references: Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9231-6
references: 11470892
references: Nature. 1992 May 21;357(6375):249-52
references: 1375347
references: Immunology. 2008 Mar;123(3):326-38
references: 17983439
references: Science. 1996 Oct 25;274(5287):618-20
references: 8849454